معرفی
Al B. Benson III, MD, is a Professor of Medicine in the Division of Hematology/Oncology at Northwestern University's Feinberg School of Medicine. He serves as Associate Director for Cooperative Groups at the Robert H. Lurie Comprehensive Cancer Center and holds clinical appointments at Northwestern Memorial Hospital, Jesse Brown VA Medical Center, and Shirley Ryan AbilityLab.
Dr. Benson's educational background includes:
- MD from State University of New York at Buffalo (1976)
- Internal Medicine Residency at University of Wisconsin Hospitals (1979)
- Oncology Fellowship at University of Wisconsin Clinical Cancer Center (1984)
His research focuses on gastrointestinal malignancies including colorectal, pancreatic, gastric, esophageal, appendiceal, anal, and neuroendocrine cancers. He leads clinical trials, develops biologic therapies, and creates evidence-based guidelines through NCCN and ASCO, with significant contributions to health services research and cancer care delivery systems.
Recent publications emphasize consensus guidelines for rare gastrointestinal cancers and peritoneal metastases, alongside studies addressing systemic challenges in academic oncology research infrastructure and resource allocation.
His extensive honors include:
- ASCO Statesman Award (Fellow of ASCO)
- NCCN Rodger J. Winn award
- ACCC Outstanding Achievement in Clinical Research Award
- Cancer Care Physician of the Year Award
- Fellow of ACCC (FACCC)
- Recognition for Service Award (Fellows), ACCC
- Best Doctors in America
- Chicago's Top Doctors
- Guide to America's Top Oncologist
- Marquis' Who's Who in Medicine and Healthcare
- Top Doctors: Chicago Metropolitan Area
- Who's Who in America
- Who's Who in Medical Sciences Education
- Top Doctors in Cancer, Chicago Magazine
Dr. Benson has secured NIH funding for multiple clinical trials and provides leadership for ECOG-ACRIN and NCCN, driving collaborative research in gastrointestinal oncology through guideline development and trial design.
He directs cooperative group activities at the Lurie Cancer Center and collaborates with international consortia including the International Rare Cancers Initiative and ECOG-ACRIN Cancer Research Group to advance treatment for rare malignancies.
